IRCT20160706028815N5 IRCT 2020-05-05 Sabzevar University of Medical Sciences The effect of addition of selenium to treatment regimen of hospitalized patients with corona on the outcome of disease compared with control group The effect of addition of selenium to treatment regimen of hospitalized patients with COVID-19 on the outcome of disease compared with control group 2020-05-20 anticipated 40 Complete https://irct.ir/trial/47682 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients are divided into two groups using a simple random method (table of random numbers). To produce table of random numbers, we will use https://www.random.org with a range of numbers 1-40 (equal to sample size). Then after, patients will enroll to the study based on their referral/visit considering the table of random numbers. 2 COVID-19 treatment. Intervention 1: Intervention group: Intervention group until discharge, in addition to antiviral treatments according to the national protocol, injectable selenium will be prescribed in the form of 1000 micrograms every 12 hours on the first day and then 500 micrograms every 12 days from the second day onwards. Intervention 2: Control group: the control group until discharge will receive antiviral treatments according to the national protocol. Yes - There is a plan to make this available What will be shared: Clinical information (including therapeutic outcomes), laboratory and demographic of Coronavirus patients 2019 under treatment with routine and selenium When: About 5 to 10 months after the start of the study To whom: Public Conditions: Careful study information can be provided to qualified researchers interested in treating patients. Where to obtain: Corresponding author How to obtain: Competent and enthusiastic researchers can receive data documentation from the responsible author after presenting the work by presenting their academic information and identification. Comments: